Epidemiological profile of
Neisseria meningitidis
multilocus sequence typing
nucleic acid amplification techniques
penicillin G
Journal
Access microbiology
ISSN: 2516-8290
Titre abrégé: Access Microbiol
Pays: England
ID NLM: 101746927
Informations de publication
Date de publication:
2020
2020
Historique:
received:
07
04
2020
accepted:
30
06
2020
entrez:
16
11
2020
pubmed:
17
11
2020
medline:
17
11
2020
Statut:
epublish
Résumé
Surveillance of invasive meningococcal diseases (IMD) must be carried out regularly and continuously in order to detect the emergence of strains of reduced susceptibility to antibiotics for therapeutic and prophylactic use and the appearance of new invasive clones. Molecular-typing approaches allow reliable traceability and powerful epidemiological analysis. This is an epidemiological study of
Identifiants
pubmed: 33195986
doi: 10.1099/acmi.0.000157
pii: 000157
pmc: PMC7656187
doi:
Types de publication
Journal Article
Langues
eng
Pagination
acmi000157Informations de copyright
© 2020 The Authors.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest.
Références
J Clin Microbiol. 1996 Mar;34(3):588-91
pubmed: 8904420
Epidemiol Infect. 2006 Dec;134(6):1203-7
pubmed: 16740192
Travel Med Infect Dis. 2011 Mar;9(2):60-6
pubmed: 21345738
Antimicrob Agents Chemother. 2012 May;56(5):2268-72
pubmed: 22290951
Eur J Clin Microbiol Infect Dis. 2002 Jun;21(6):483-5
pubmed: 12111610
Lancet. 1990 Apr 7;335(8693):863-4
pubmed: 1969594
Antimicrob Agents Chemother. 2010 Mar;54(3):1016-21
pubmed: 20086160
Methods Mol Biol. 2012;799:1-20
pubmed: 21993636
Emerg Infect Dis. 2016 Apr;22(4):698-702
pubmed: 26982628
J Med Microbiol. 2004 Sep;53(Pt 9):921-925
pubmed: 15314201
PLoS One. 2013;8(3):e58065
pubmed: 23483970
Infect Dis (Lond). 2018 Sep;50(9):697-704
pubmed: 29623748
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29914967
Lancet Infect Dis. 2013 May;13(5):416-25
pubmed: 23414709
Euro Surveill. 2018 Jul;23(28):
pubmed: 30017022
J Infect. 2015 Nov;71(5):544-52
pubmed: 26226598
J Adolesc Health. 2016 Aug;59(2 Suppl):S21-8
pubmed: 27449146
East Mediterr Health J. 2016 Aug 18;22(5):343-9
pubmed: 27553401
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3140-5
pubmed: 9501229
Enferm Infecc Microbiol Clin. 2011 Feb;29(2):85-9
pubmed: 21345528
Hum Vaccin Immunother. 2015;11(9):2281-6
pubmed: 26036710
J Infect. 2018 Feb;76(2):149-158
pubmed: 29132919
Int J Infect Dis. 2020 Feb;91:73-78
pubmed: 31756567
Expert Rev Vaccines. 2017 Apr;16(4):313-328
pubmed: 27820969
Emerg Infect Dis. 2018 Nov;24(11):2080-2083
pubmed: 30334720
Vaccine. 2011 Apr 18;29(18):3363-71
pubmed: 21376800
J Clin Microbiol. 2018 Jun 25;56(7):
pubmed: 29743304
Vaccine. 2016 Jul 25;34(34):4068-71
pubmed: 27291085
J Infect. 2017 Jun;74(6):564-574
pubmed: 28279715
J Med Microbiol. 2018 Jun;67(6):750-756
pubmed: 29717974
J Infect. 2017 Jul;75(1):1-11
pubmed: 28455205
Pathol Biol (Paris). 2006 Apr;54(3):166-70
pubmed: 16442242
Euro Surveill. 2012 Aug 23;17(34):
pubmed: 22939210
Eur J Clin Microbiol Infect Dis. 2004 Jul;23(7):517-22
pubmed: 15221618
PLoS One. 2016 Mar 07;11(3):e0150721
pubmed: 26950303
Mol Biol Evol. 1999 Nov;16(11):1496-502
pubmed: 10555280
Hum Vaccin Immunother. 2013 Jan;9(1):162-71
pubmed: 23108355
J Clin Microbiol. 2000 Feb;38(2):855-7
pubmed: 10655397
Clin Infect Dis. 2003 Oct 1;37(7):912-20
pubmed: 13130402
J Clin Microbiol. 2000 Dec;38(12):4492-8
pubmed: 11101585
Int J Infect Dis. 2019 Aug;85:37-48
pubmed: 31085314